Branched-chain amino acids deficiency promotes diabetic cardiomyopathy by activating autophagy of cardiac fibroblasts
2024

BCAA Deficiency and Diabetic Cardiomyopathy

Sample size: 15 publication Evidence: moderate

Author Information

Author(s): Zhou Ze-Yu, Song Kai, Liu Zhi-Yan, Ke Yu-Fan, Shi Yan, Cai Ke, Zhao Rui, Sun Xin, Tao Hui, Zhao Jian-Yuan

Primary Institution: Institute for Developmental and Regenerative Cardiovascular Medicine, MOE-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Hypothesis

Does branched-chain amino acids (BCAAs) deficiency promote diabetic cardiomyopathy by activating autophagy in cardiac fibroblasts?

Conclusion

BCAA supplementation may serve as a potential therapeutic agent to mitigate diabetic cardiomyopathy and fibrosis.

Supporting Evidence

  • BCAA levels were significantly lower in DCM patients compared to T2D patients without cardiomyopathy.
  • BCAA deficiency aggravated cardiomyopathy phenotypes in diabetic mouse models.
  • BCAA supplementation improved cardiac function and reduced fibrosis in DCM mice.

Takeaway

If you don't have enough branched-chain amino acids, your heart can get sick when you have diabetes. Eating more of these can help keep your heart healthy.

Methodology

The study involved metabolite profiling in patients and mouse models to assess the effects of BCAA levels on diabetic cardiomyopathy.

Limitations

The small clinical sample size may limit the statistical power, and the reasons for lower BCAA levels in DCM patients were not explored.

Participant Demographics

15 DCM patients and 19 age- and sex-matched T2D patients.

Statistical Information

P-Value

0.009

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.7150/thno.102708

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication